Results 91 to 100 of about 6,798 (212)
In vitro cytotoxicity (IC50 ng/ml) of ABT-737, ABT-263, or ABT-199 in combination with Mel-14-PE38KDEL immunotoxin.
Mikhail Dobrikov (3067083) +7 more
core +1 more source
GrB/scFvMEL, a fusion protein composed of human granzyme B (GrB) and the single-chain antibody scFvMEL, targets melanoma gp240 antigen and exerts impressive cytotoxic effects by inducing apoptosis. We evaluated the effects of GrB/scFvMEL on chemotherapy,
Yuying Liu +6 more
doaj +1 more source
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
T cell epitopes and its use as an immunotoxin warhead
Fungal ribotoxins that block protein synthesis can be useful warheads in the context of a targeted immunotoxin. α-Sarcin is a small (17 kDa) fungal ribonuclease produced by Aspergillus giganteus that functions by catalytically cleaving a single ...
Kurt R. Gehlsen +17 more
core +1 more source
The noradrenergic (NA) neurons in the locus ceruleus (LC) were ablated with a high degree of selectivity by immunotoxin-mediated neuronal targeting. Transgenic mice were used in which the human interleukin-2 receptor-α subunit (hIL-2Rα; Tac) is expressed
Saya Suzuki +8 more
core +1 more source
Acute Lymphoblastic Leukemia (ALL) remains the most frequent cause of cancer-related mortality in children and novel therapies are needed for the treatment of relapsed/refractory childhood ALL.
Monika Bokori-Brown +10 more
doaj +1 more source
Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19+ tumors
CD19 is expressed on normal and neoplastic B cells and is a promising target for immunotherapy. However, there is still an unmet need to further develop novel therapeutic drugs for the treatment of the refractory/relapsing human CD19+ tumors.
Huang, Qi +7 more
core +1 more source
EGFR-targeted therapies are efficacious, but toxicity is common and can be severe. Urokinase type plasminogen activator receptor (uPAR)-targeted drugs are only emerging, so neither their efficacy nor toxicity is fully established.
Rose H. Dicovitsky +24 more
doaj +1 more source
Prostate cancer is one of the most prevalent malignancies in men and a leading cause of cancer-related mortality. The prostate-specific membrane antigen (PSMA), which is highly overexpressed in prostate tumors and internalized upon ligand binding ...
Mousavipour, Sara, Mousavi-Niri, Neda
core +1 more source
PDF file- 129 KB, Supplementary Methods; Supplementary Figure S1: Potentiator binding and cytotoxicity; Supplementary Figure S2: Potentiator hemolytic activity; Supplementary Figure S3: Potentiation of gelonin immunotoxin cytotoxicity; Supplementary ...
K. Dane Wittrup (1294554) +2 more
core +1 more source

